Profile

Cover photo
Moffitt Cancer Center
119 followers|16,980 views
AboutPostsPhotosYouTube

Stream

Moffitt Cancer Center

Shared publicly  - 
 
Moffitt Cancer Center Researchers discover mechanism leading to BRAF inhibitor resistance in melanoma patients. Mutations in the gene BRAF are the most common mutation found in melanoma, with up to 50 percent of tumors testing positive for the mutations. Several agents that directly target BRAF have been approved by the Food and Drug Administration for the treatment of melanoma patients who have the mutation, including dabrafenib and vemurafenib. Read more at: http://ow.ly/Ouvv3
1
Add a comment...

Moffitt Cancer Center

Shared publicly  - 
 
How do you overcome your fears? #MotivationalMonday
1
1
Sonya Thomas-Webb, D.D.S., P.C.'s profile photo
Add a comment...

Moffitt Cancer Center

Shared publicly  - 
 
Moffitt Cancer Center has received the Diversity Award by Premier Inc. for supporting supply chain diversity as part of its social responsibility initiatives.
It was announced that Moffitt is the only Premier member to receive the Diversity Award this year during Premier’s annual Breakthroughs Conference and Exhibition in National Harbor, Md., held June 24. The award honors health systems that have established active programs to evaluate and support minority-, women- and veteran-owned enterprises, as well as small businesses, available through the Premier contract portfolio.
“Moffitt's commitment to supplier diversity is not just because of social responsibility,” says Jack Kolosky, Moffitt’s Chief Operating Officer. “We think it is good business practice to enhance relationships with diverse businesses. They help us build an outstanding group of suppliers who benefit our patients, providers, employees and researchers.
Members of Premier, a leading healthcare improvement company, apply for the Diversity Award and are measured on engagement in diversity initiatives through community involvement, diversity business outreach initiatives, benchmarking and best practices sharing.
“This recognition further solidifies our center-wide commitment to increasing the participation and inclusion of diverse suppliers to compete in Moffitt's purchasing, proposal and/or bid opportunities,” says Desiree Hanson, Moffitt’s supplier diversity manager.
Premier president of supply chain services Durral R. Gilbert praised Moffitt’s efforts.
“Moffitt Cancer Center is at the forefront of innovative diversity programs that benefit the communities, businesses and a people they serve,” says Gilbert. “We welcome collaboration with diverse suppliers and encourage health systems to use their highly-valued products and services.”
Premiere Inc. unites an alliance of approximately 3,400 U.S. hospitals and 110,000 other providers to transform healthcare. Headquartered in Charlotte, N.C., Premier collaborates with members to co-develop long-term innovations that reinvent and improve the way care is delivered to patients nationwide.
1
Add a comment...

Moffitt Cancer Center

Shared publicly  - 
 
Eat the rainbow: the brighter the color, the more flavonoids and carotenoids, which lower inflammation. (We’re talking about fruits and vegetables, Skittles and candies do not count). Strive for 10 handful size servings of colorful fruits and veggies each day to maximize their health benefits.
1
1
Cristine Lafemina's profile photo
Add a comment...

Moffitt Cancer Center

Shared publicly  - 
 
Cindy Terrano has been named as the new Vice President of Payer Strategies at Moffitt Cancer Center. She steps into the newly created position this week.
“This is a new role at Moffitt which is critical to the success of our strategic plan as we continue to partner with payers and other organizations,” says Yvette Tremonti, executive vice president of strategy and business development.
http://ow.ly/OCSTJ
1
Add a comment...

Moffitt Cancer Center

Shared publicly  - 
 
A look at the main entrance of the new Moffitt McKinley Outpatient Center, a 33,000 square-foot surgery center, scheduled to open late this fall.
1
Add a comment...
Have them in circles
119 people
Champions Oncology's profile photo
Marlin Davis's profile photo
Kerrie Thomsen's profile photo
Tampa Bay Farmers Market, Inc.'s profile photo
HealthMyne's profile photo
Luz C Lopez's profile photo
Lindsay Fogleman's profile photo
Bethzaida alvarado's profile photo
davood heidari's profile photo

Moffitt Cancer Center

Shared publicly  - 
 
Moffitt Cancer Center received a $3.6 million grant from the National Institutes of Health to study the use of electronic cigarettes, or e-cigarettes, over the next five years. Although very little is known about the safety of these new products, they are thought to be much less dangerous than conventional cigarettes. Most e-cigarette users report that they began using the product in an attempt to quit or cut down on smoking. However, there has been little research to date on the effectiveness of e-cigarettes for quitting smoking.
The goal of the new Moffitt grant is to learn how e-cigarettes are used over time, and whether users are eventually successful at quitting smoking. During the first year of the study, Moffitt researchers will be interviewing e-cigarette users to learn about their experiences and their perceptions of the pros and cons of e-cigarettes. The researchers want to interview current and former smokers who are also current or former e-cigarettes users. Read more at http://ow.ly/OWqH7
1
Add a comment...

Moffitt Cancer Center

Shared publicly  - 
 
"Some say two heads are better than one. And they may be right. The collaborative efforts of two Moffitt scientists in particular would seem to bear this out." Alan List, MD, Moffitt president and CEO collaborates with Shend Wei, MD to lead a team that is converging immunology and hematology to develop a novel therapy for certain types of cancers. Learn more about this collaboration and what they are achieving at http://ow.ly/N9MCR.
1
Add a comment...

Moffitt Cancer Center

Shared publicly  - 
 
Immunotherapy is an exciting approach that can result in the regression of bulky, invasive cancer in some patients. Much progress has been made in our understanding of the role of the host immune response in affecting tumor progression and response to various treatments. In this issue of Cancer Control, experts review the latest clinical and therapeutic aspects of emerging
immunotherapies for numerous disease sites. http://ow.ly/OrE2T
1
Add a comment...

Moffitt Cancer Center

Shared publicly  - 
 
If you are a man between the ages of 65 and 75 and have ever smoked more than 100 cigarettes, which condition should you be screened for? #MensHealthMonth
A. Abdominal aortic aneurysm
B. Smoking
C. Prostate cancer
D. All of the above
1
Add a comment...

Moffitt Cancer Center

Shared publicly  - 
 
Moffitt Cancer Center Researchers discover mechanism leading to BRAF inhibitor resistance in melanoma patients. More than half of all melanoma patients have a BRAF mutation; many become resistant to BRAF inhibitor treatment and relapse.
Mutations in the gene BRAF are the most common mutation found in melanoma, with up to 50 percent of tumors testing positive for the mutations. Several agents that directly target BRAF have been approved by the Food and Drug Administration for the treatment of melanoma patients who have the mutation, including dabrafenib and vemurafenib. However, many patients become resistant to BRAF inhibitors and relapse. This resistance is associated with reactivation of the BRAF protein communication pathway in tumor cells. Read more at: http://ow.ly/Ouvv3
1
2
Lindsay Fogleman's profile photoOncology Central's profile photo
Add a comment...

Moffitt Cancer Center

Shared publicly  - 
 
Latina Women Undergoing Chemotherapy for Breast Cancer Need More Culturally Relevant, Language-Specific Stress Management Tools, Say Moffitt and USF Researchers.
Familial obligations and relationships are stress-inducers for Latina cancer patients that must be recognized by health care providers and educators. Cancer is the most common cause of death among Latinos. It is estimated that one out of every three Latina women will be diagnosed with cancer during her lifetime. Given the increasing Latino population in the United States, more emphasis has to be placed on educating this population about cancer. Moffitt Cancer Center researchers, along with collaborators at the University of South Florida, recently published a study about the attitudes and cultural perspectives of Latinas undergoing chemotherapy for breast cancer. The article also discusses their cancer experiences and the ways they manage stress associated with cancer. More at:
1
Add a comment...
People
Have them in circles
119 people
Champions Oncology's profile photo
Marlin Davis's profile photo
Kerrie Thomsen's profile photo
Tampa Bay Farmers Market, Inc.'s profile photo
HealthMyne's profile photo
Luz C Lopez's profile photo
Lindsay Fogleman's profile photo
Bethzaida alvarado's profile photo
davood heidari's profile photo
Contact Information
Contact info
Phone
813-745-3980
Email
Address
12902 Magnolia Drive Tampa, Fla. 33612
Story
Tagline
Moffitt Cancer Center is your best chance for beating cancer. Learn more at MOFFITT.org.
Introduction
Moffitt belongs to an elite group of cancer centers that has achieved distinction from the National Cancer Institute (NCI). As the only NCI-designated Comprehensive Cancer Center based in Florida, Moffitt is working tirelessly in the areas of patient care, research and education – developing early-stage translational research aimed at the rapid translation of scientific discoveries to benefit patients.

We provide a level of care that stands above the rest. Our team of experts provides a plan that’s right for you, right from the start. The results are shorter treatment times, reduced hospital stays, and improved quality of life during and after treatment. For you that means better outcomes, and your best chance for beating cancer.